Comparative analysis of artificial intelligence chatbots in health care: Managing diabetic ketoacidosis during the COVID-19 era

Conflict of interest

The authors declare they have no competing interests.

References

[1] Mirjalili H, Dastgheib SA, Shaker SH, et al. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension, and cardiovascular disease patients with COVID-19: A meta-analysis. J Diabetes Metab Disord. 2021; 20:905-917. doi: 10.1007/s40200-021-00768-5

[2] Karimi-Zarchi M, Sayad S, Vakili M, et al. A collect of recommendations and guidelines for management and treatment of underlying malignancies during the COVID-19 pandemic. Acta Med Iran. 2023; 61:443-448. doi: 10.18502/acta.v61i8.14900

[3] Kooli C, Al Muftah H. Artificial intelligence in healthcare: A comprehensive review of its ethical concerns. Technol Sustain. 2022; 1:121-131. doi: 10.1108/TECHS-12-2021-0029

[4] Shimada K. The role of artificial intelligence in mental health: A review. Sci Insights. 2023; 43:1119-1127. doi: 10.15354/si.23.re820

[5] Ishii K, Suwanai H, Saito T, et al. A case of diabetic ketoacidosis in a patient with COVID-19 and newly diagnosed type 1 diabetes. Clin Case Rep. 2021; 9:e04881. doi: 10.1002/ccr3.4881